Business Wire

NC-SYNECHRON

1.4.2016 08:01:26 CEST | Business Wire | Press release

Share
Synechron to Integrate Double Effect and Team Trade to Bolster Its Consulting and Technology Capabilities

Synechron, one of the fastest growing digital, business consulting and technology service providers, announced its corporate brand integration with Double Effect and Team Trade - companies it had acquired in the past few years, to further augment its consulting and technology capabilities. Post-acquisition, Double Effect and Team Trade were operating as independent entities and brands. However, this brand integration strategy will see both these entities merging into the parent company – Synechron, fortifying the overall consulting and technology business/practice. As part of Synechron’s recently announced ‘Power of 3’ strategy, this move is also aimed at providing all consulting and technology services combined with digital under a single brand umbrella in order to leverage Synechron’s robust brand equity, also fueling its ambition of being a billion dollar company by 2020.

Founded in 2003 in Amsterdam, Double Effect houses 100+ business consultants spread across eight global locations. The Dutch consulting firm works for banking and financial institutions including corporate, investment and retail banks, asset management companies and pension as well as insurance services. In 2013, Double Effect became part of the Synechron group.

Team Trade, founded in 2000, is a Paris-based firm specializing in business consulting and financial software integration. The firm has significant presence in Paris, Luxembourg, Milan, London, New York and Singapore covering the European, North American and Asian markets. Team Trade became part of the Synechron group in December 2014.

“Double Effect’s business consulting portfolio is perfectly aligned with the geographical, business, client and service coverage of Synechron. By operating as a consulting arm of the Synechron brand, all our client relationships and alliances will witness a greater value addition through our combined capabilities. We are very excited about this transformation,” said Bas Heijnen, Managing Director, Double Effec t on this occasion.

“Considering the roll out of the recent business transformation strategy by Synechron, this is the right time for brand integration of Team Trade with Synechron as providing technology and consulting services under the merged identity will have a positive impact in the eyes of clients and other stakeholders,” said Pascal Rellier, Managing Director, Team Trade .

“For Synechron, Double Effect and Team Trade, this mutually beneficial move is a major opportunity for offering a niche, augmented set of technology as well as consulting services for the financial services industry. This brand integration will add more depth to Synechron’s current value proposition and enable our global clients to avail business solutions with a 360-degree perspective, encompassing business consulting and technology combined with digital transformation services under a single roof,” commented Faisal Husain, Co-founder and Chief Executive Officer, Synechron .

This brand integration will come into effect on April 4, 2016 and will be a critical step for Synechron in order to strategically re-align its technology and consulting service capabilities in all its service lines.

About Synechron

Synechron, one of the fastest-growing digital, business consulting & technology services providers, is a $350 million firm based in New York. Since inception in 2001, Synechron has been on a steep growth trajectory. With 5,000+ professionals operating in 16 countries across the world, it has presence across USA, Canada, UK, France, The Netherlands, Switzerland, Luxembourg, Serbia, Germany, Italy, UAE, Singapore, Hong Kong, Japan, Australia and Development Centers in India. Visit us at www.synechron.com .

Contact:

Synechron
Atul Tajave
Manager - Global Marketing & Communication
synechron-mediarelations@synechron.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye